Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/01/1999 | WO1999015644A2 Method for the identification of essential genes and therapeutic targets |
04/01/1999 | WO1999015643A2 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO ANGIOTENSI N CONVERTING ENZYME mRNA AND METHODS OF USE |
04/01/1999 | WO1999015642A1 Lunasin peptides |
04/01/1999 | WO1999015641A1 Non-primate lentiviral vectors and packaging systems |
04/01/1999 | WO1999015640A1 Detecting cow, sheep and pig prions in a sample and transgenic animal used for same |
04/01/1999 | WO1999015639A1 Polymorphic cag repeat-containing gene and uses thereof |
04/01/1999 | WO1999015638A1 Rapid thermal cycle processing methods and apparatus |
04/01/1999 | WO1999015636A1 Expression of starch-binding domain (sbd) |
04/01/1999 | WO1999015635A1 Human ste20-like stress activated serine/threonine kinase |
04/01/1999 | WO1999015633A1 Novel cyclomaltodextrin glucanotransferase variants |
04/01/1999 | WO1999015632A1 ENZYMATIC PROCESS FOR THE PREPARATION OF CEPHALOSPORANIC 7$b(g)-(4-CARBOXYBUTANAMIDE) ACID BY MEANS OF THE MODIFIED ENZYME D-AMINOACID OXIDASE OF TRIGONOPSIS VARIABILIS PRODUCED IN $i(ESCHERICHIA COLI) |
04/01/1999 | WO1999015631A1 Recombinant rsv virus expression systems and vaccines |
04/01/1999 | WO1999015630A1 Artificial viruses derived from papillomavirus, and their uses, in particular gene therapy |
04/01/1999 | WO1999015623A1 Recombinant yeast cell and assay using same |
04/01/1999 | WO1999015563A1 Catalytic antibodies and a method of producing same |
04/01/1999 | WO1999015558A1 Warts protein, polynucleotide encoding the same, antisense polynucleotide thereof, and antibody recognizing the protein |
04/01/1999 | WO1999015556A1 Huchordin and uses thereof |
04/01/1999 | WO1999015554A2 Ras-like protein |
04/01/1999 | WO1999015553A2 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use |
04/01/1999 | WO1999015551A1 Novel receptor |
04/01/1999 | WO1999015550A1 Ucp3 genes |
04/01/1999 | WO1999015549A2 Peptide sequences as hinge regions in proteins like immunoglobulin fragments and their use in medicine |
04/01/1999 | WO1999015548A2 Isolated and recombinant antimicrobial peptides thrombocidin-1 (tc-1) and thrombocidin-2 (tc-2) or variants thereof |
04/01/1999 | WO1999015545A1 G-protein coupled glycoprotein hormone receptor aomf05 |
04/01/1999 | WO1999015206A1 Methods for preparing lipids/polynucleotide transfection complexes |
04/01/1999 | WO1999015200A1 MEDICINAL COMPOSITION CONTAINING gp34 BINDING INHIBITOR AS THE ACTIVE INGREDIENT |
04/01/1999 | WO1999015199A1 Antigen presenting mesenchymal stem cells |
04/01/1999 | WO1999015197A1 Preparation for the therapy of disorders related to blood clotting |
04/01/1999 | WO1999015009A2 TRYPSIN INHIBITORS WITH INSECTICIDAL PROPERTIES OBTAINED FROM $i(PENTACLETHRA MACROLOBA) |
04/01/1999 | WO1999015004A1 Method for altering storage organ composition |
04/01/1999 | WO1999015003A1 Methods and compositions for transformation of cereals using cultured shoot meristematic tissue |
04/01/1999 | WO1999004008A3 Cloned genomes of infectious hepatitis c viruses and uses thereof |
04/01/1999 | WO1999002708A8 Fusion proteins comprising sequences derived from bovine if1 atpase inhibitor protein |
04/01/1999 | WO1999002704A3 Dual specifically phosphatase and methods of use |
04/01/1999 | WO1999002673A3 Antisense oligonucleotide sequences as inhibitors of microorganisms |
04/01/1999 | WO1999002669A3 Production of polyketides in plants |
04/01/1999 | WO1999002566A3 Standardised protein |
04/01/1999 | WO1999002564A3 Ancrod specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and use of the same |
04/01/1999 | WO1999002552A3 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
04/01/1999 | WO1999002545A3 Antigen binding fragments, designated 4b5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
04/01/1999 | WO1999001551A3 Novel inhibitor of cellular proliferation |
04/01/1999 | WO1998056930A3 Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells |
04/01/1999 | WO1998055615A9 Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
04/01/1999 | WO1998055614A3 Secreted proteins and polynucleotides encoding them |
04/01/1999 | WO1998055611A9 Neuregulin response element and uses therefor |
04/01/1999 | WO1998054327A9 Proteins having insecticidal activities and method of use |
04/01/1999 | WO1998054325A9 Human frp and fragments thereof including methods for using them |
04/01/1999 | WO1998054313A3 Dna methyltransferase genomic sequences and antisense oligonucleotides |
04/01/1999 | WO1998054214A9 Hypersensitive response elicitor fragments and uses thereof |
04/01/1999 | WO1998053856A9 Methods for the detection, treatment, and prevention of neurodegeneration |
04/01/1999 | WO1998053076A3 Compounds for diagnosis of tuberculosis and methods for their use |
04/01/1999 | WO1998053075A3 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
04/01/1999 | WO1998052964A9 Rupestris stem pitting associated virus nucleic acids, proteins, and their uses |
04/01/1999 | WO1998052581A9 Vectors and methods for immunization or therapeutic protocols |
04/01/1999 | WO1998051824A9 Reagents and methods useful for detecting disease of the urinary tract |
04/01/1999 | WO1998051787A3 Gene construct encoding a heterologous prodrug-activating enzyme and a cell targeting moiety |
04/01/1999 | WO1998051321A9 Tissue factor for influencing blood vessel formation |
04/01/1999 | WO1998050554A3 Enterococcus faecalis polynucleotides and polypeptides |
04/01/1999 | WO1998050430A3 Hemoglobin mutants with increased soluble expression and/or reduced nitric oxide scavenging |
04/01/1999 | WO1998049332A8 Agrobacterium mediated transformation of sorghum |
04/01/1999 | WO1998046747A9 Genes in the non-recombining region of the y chromosome |
04/01/1999 | WO1998039464A8 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
04/01/1999 | WO1998039363A3 Immunotoxins and methods of inducing immune tolerance |
04/01/1999 | WO1998014592A3 Telomerase reverse transcriptase |
04/01/1999 | DE19741375A1 Transgene Pflanzen, deren oberirdische Teile früher reifen und vollständig absterben Transgenic plants ripen their aerial parts earlier and completely die |
04/01/1999 | CA2820212A1 Recombinant rsv virus expression systems and vaccines |
04/01/1999 | CA2619698A1 Lkta deletion mutant of p. haemolytica |
04/01/1999 | CA2308002A1 Novel cyclomaltodextrin glucanotransferase variants |
04/01/1999 | CA2305377A1 Microspore-specific promoter and method for obtaining hybrid plants |
04/01/1999 | CA2305350A1 Costimulating polypeptide of t cells, monoclonal antibodies, and the preparation and use thereof |
04/01/1999 | CA2305016A1 Human complement c3-degrading proteinase from streptococcus pneumoniae |
04/01/1999 | CA2304986A1 G-protein coupled glycoprotein hormone receptor aomf05 |
04/01/1999 | CA2304983A1 Non-primate lentiviral vectors and packaging systems |
04/01/1999 | CA2304932A1 Recombinant rsv virus expression systems and vaccines |
04/01/1999 | CA2304895A1 Normalized nucleic acid libraries and methods of production thereof |
04/01/1999 | CA2304847A1 Recombinant yeast cell and assay using same |
04/01/1999 | CA2304828A1 G-protein coupled glycoprotein hormone receptor hg38 |
04/01/1999 | CA2304793A1 Warts protein, polynucleotide encoding the same, antisense polynucleotide thereof, and antibody recognizing the protein |
04/01/1999 | CA2304746A1 Novel molecules of the tnf receptor superfamily and uses therefor |
04/01/1999 | CA2304642A1 Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna |
04/01/1999 | CA2304569A1 Petal-specific promoter and method for obtaining plants having flowers with no petals |
04/01/1999 | CA2304485A1 Human regulatory molecules |
04/01/1999 | CA2304369A1 Method for the identification of essential genes and therapeutic targets |
04/01/1999 | CA2304365A1 Catalytic antibodies and a method of producing same |
04/01/1999 | CA2304259A1 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site |
04/01/1999 | CA2304173A1 Plasmids for construction of eukaryotic viral vectors |
04/01/1999 | CA2304168A1 Methods and cell line useful for production of recombinant adeno-associated viruses |
04/01/1999 | CA2304131A1 Method for gene transfer using bcl2 and compositions useful therein |
04/01/1999 | CA2304129A1 Tie ligand homologues |
04/01/1999 | CA2304126A1 Cell growth regulator |
04/01/1999 | CA2304109A1 Banana proteins, dna, and dna regulatory elements associated with fruit development |
04/01/1999 | CA2304102A1 Insulin-like polypeptide and uses therefor |
04/01/1999 | CA2303911A1 Method for altering storage organ composition |
04/01/1999 | CA2303762A1 Megsin protein |
04/01/1999 | CA2303760A1 A potential effector for the grb7 family of signalling proteins |
04/01/1999 | CA2303663A1 Expression of genes in hematopoietic stem cells in hischaemic conditions |
04/01/1999 | CA2303405A1 53bp2 complexes |
04/01/1999 | CA2303399A1 Rapid thermal cycle processing methods and apparatus |
04/01/1999 | CA2303003A1 Ucp3 genes |
04/01/1999 | CA2302993A1 Mutants of thyroid stimulating hormone and methods based thereon |